Evidence primers
Clear, non-technical summaries of study types and what conclusions they can support.
About
Regenegaine Research is a newly launched independent information company helping people understand Ibogaine Neuroregeneration: How The Idea Developed. We publish clear, evidence-first summaries, organize primary sources, and explain how the research community approaches regenerative hypotheses.
Independent
Evidence-first
Transparent sourcing
Our homepage presents the project's central framing and access points; for a guided view of what we offer, the site navigation points to practical sections such as an overview of our services and resources and editorial primers. For context about treatment access and providers abroad we also link to external treatment directories where appropriate, for example a clinical resource that describes regional programs at Ibogaine Treatment Europe.
Our editorial approach
We focus on compiling, summarizing and contextualizing peer-reviewed literature, public registries, and official reports so readers can follow the evidentiary trail. Our team organizes coverage by document type (reviews, clinical trials, registries), and uses transparent notes on methodology and limitations for each summary.
To underline how we verify claims, we draw on public registries and institutional pages for cross-checking; for example, methodological best-practices in clinical research are described on pages like the National Institutes of Health's clinical trials guidance, which we consult when evaluating study design and reporting standards (ClinicalTrials.gov).
What we cover
Regenegaine Research curates long-form explainers, concise evidence primers, and resource indexes related to Ibogaine Neuroregeneration: How The Idea Developed. Content is organized into topical sections, editorial primers, and a services page that describes non-clinical offerings such as literature synthesis and evidence-mapping; see our description of services on the services and resources page for details.
Document registry
Organized indices of trials, case series and review articles with provenance notes.
Method notes
Plain-language explanations of research methods and common limitations.
Who this is for
Our audience includes readers seeking an evidence-oriented orientation to the literature, students preparing literature reviews, and professionals who want consolidated citations. We explicitly avoid offering clinical recommendations; our material is informational and intended to support informed discussion and further inquiry.
Where users need details on treatments or providers, we point to established domain resources and registries rather than presenting ourselves as a clinical provider; an example of an external resource used for regional context is Ibogaine Treatment Europe, which lists regional programs and provider information.
Editorial principles
- Independence: We publish without financial ties to clinics or commercial providers.
- Clarity: We prefer plain language and clear explanations of uncertainty.
- Accuracy: All claims are tied to cited documents, registries or institutional guidance.
- Transparency: We disclose limitations and editorial methods for each synthesis.
How we organize content
Our site is modelled as a lightweight editorial dashboard: each topic page links to source lists, short summaries, and a curated reading path. This structure helps readers move from introductory primers to primary documents efficiently.
Interface previews
Module-based pages show the top-line conclusion, a methods note, and direct links to the source documents. Navigation between pages is built to surface related primers and the central homepage narrative so readers keep context; for example, the homepage provides entry points back to thematic sections such as our central overview and starting point.
Workflows
When we summarize a paper we flag study design, sample size, outcome measures, and any registry entries; this mirrors recommended practices used by systematic-review groups and registries such as those described by the Cochrane collaboration (Cochrane).
Design and media
Photography and source documents are used to support editorial narratives. Images are presented with clear captions and alt text to improve accessibility and preserve the visual context of our summaries.
Independent by design
Regenegaine Research is an independent information company, not a clinic or medical provider. The content we provide is informational and not medical or legal advice. Readers seeking clinical guidance should consult licensed professionals and official registries.
We aim to be transparent about limitations: methodologies, conflicts of interest, and data quality are noted where relevant and are considered first-class editorial material. To support reproducibility we reference registries and institutional sources where possible; for example, public trial registries such as ClinicalTrials.gov are part of our verification workflow.